[Combined dexamethasone suppression and chorionic gonadotrophin stimulation test in the diagnosis of androgenic functional ovarian tumors].
D015068:17-Ketosteroids / Q000652:urine; D000230:Adenocarcinoma / Q000175:diagnosis; D000328:Adult; D000728:Androgens / Q000096:biosynthesis; D006063:Chorionic Gonadotropin; D003687:Dehydroepiandrosterone / Q000652:urine; D003907:Dexamethasone; D005260:Female; D006801:Humans; D007984:Leydig Cell Tumor / Q000175:diagnosis; D008722:Methods; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000378:metabolism; D018310:Sertoli-Leydig Cell Tumor / Q000175:diagnosis; D013739:Testosterone / Q000652:urine; D013798:Thecoma / Q000175:diagnosis
D015068:17-Ketosteroids; D000728:Androgens; D006063:Chorionic Gonadotropin; D013739:Testosterone; D003687:Dehydroepiandrosterone; D003907:Dexamethasone
Kombinierter Funktionstest mit Dexamethason und Choriongonadotropin zur Diagnose androgenbildender ovarialtumoren.